STAR Study - Version 1
Research type
Research Study
Full title
ShorT stay Aneurysm Repair (STAR): A 23-hour endovascular abdominal aortic aneurysm repair pathway with evaluation of eligibility, uptake, viability, acceptability, safety and cost.
IRAS ID
302827
Contact name
Colin Bicknell
Contact email
Sponsor organisation
Imperial College London
Clinicaltrials.gov Identifier
Clinicaltrials.gov Identifier
N/A, N/A
Duration of Study in the UK
2 years, 0 months, 0 days
Research summary
There has been a failure to implement day case EVAR - patient discharge after endovascular aneurysm repair (EVAR) in <24 hours, on a widespread scale in the UK. There are significant health-economic and trust resource implications associated with longer hospital stay, which are vitally important in discussions regarding the appropriateness of EVAR.
This study aims to build on previous experience and background studies to formally assess a ShorT stay Aneurysm Repair (STAR) pathway designed to accommodate patient, organisational, community, and social needs and ensure patient safety.After careful co-design of a STAR pathway with patients, carers and GPs we plan to assess (in over 200 patients) the eligibility, uptake, viability, acceptability and safety. Consecutive EVAR patients at five sites (target 100 patients) will be assessed for eligibility over 12 months. We shall determine the proportion of patients eligible for and taking up STAR.
Procedure times, details of procedural intervention, discharge and readmission will be collected to measure viability. Mortality, complications/adverse events (at 30 days, 3, 6 and 12 months), will be used to determine the safety of short stay aneurysm repair.
Acceptability will be measured by patient related outcome measures and quality of life tools measured at baseline, 30 days, 3 months and 6 months.
Cost of the pathways (including NHS, social care and societal costs will be measured.
Barriers to the wider implementation of STAR will be described by complementary qualitative focus group work involving patients and staff.
From this work we will understand the proportion of patients that could be managed with a STAR pathway safely and we intend to create a web/app based “toolkit” for effective 23-hour EVAR implementation.
REC name
London - Bromley Research Ethics Committee
REC reference
21/PR/1579
Date of REC Opinion
24 Jan 2022
REC opinion
Further Information Favourable Opinion